A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication
about
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigorCognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trialsSupportive therapy for schizophreniaCognitive behaviour therapy versus other psychosocial treatments for schizophreniaCognitive behaviour therapy versus other psychosocial treatments for schizophreniaSupportive therapy for schizophreniaSupportive therapy for schizophreniaCognitive behaviour therapy for schizophreniaCurrent perspectives in the treatment of resistant schizophreniaCognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia.Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis.Beyond dopamine: functional MRI predictors of responsiveness to cognitive behaviour therapy for psychosis.Vocational rehabilitation for adults with psychotic disorders in a Scandinavian welfare societyConverging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future study.A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol.Psychosocial interventions for schizophrenia.Effect of cognitive behaviour therapy on adjustment, intensity of symptoms and automatic thoughts in schizophreniaNo association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial.Elderly patients with schizophrenia and depression: diagnosis and treatmentToward the future of psychiatric diagnosis: the seven pillars of RDoCSuicide prevention in schizophrenia spectrum disorders and psychosis: a systematic review.Rehabilitation in the United Kingdom: research, policy, and practice.Neural changes following cognitive behaviour therapy for psychosis: a longitudinal study.Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.Narrative enhancement and cognitive therapy: a new group-based treatment for internalized stigma among persons with severe mental illness.Longitudinal designs, methods and analysis in psychiatric research.The Early Psychosis Intervention Center (EPICENTER): development and six-month outcomes of an American first-episode psychosis clinical service.Psychological treatments for early psychosis can be beneficial or harmful, depending on the therapeutic alliance: an instrumental variable analysis.Effective elements of cognitive behaviour therapy for psychosis: results of a novel type of subgroup analysis based on principal stratification.Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophreniaThe current status of psychological treatments in bipolar disorders: a systematic review of relapse prevention.The efficacy of a new translational treatment for persecutory delusions: study protocol for a randomised controlled trial (The Feeling Safe Study).Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial.Cognitive behaviour therapy for schizophrenia -- a review of development, evidence and implementation.
P2860
Q22242826-8ACE0F06-A79B-4F48-95EA-6EE0E6FD6622Q22242831-9F0920D1-75F4-4D34-ACB5-70F475C7734CQ22251387-1FD9380D-4A96-4B24-A7B8-6A2D7F88AEFAQ24186517-0906674D-5A96-4D6C-BA71-2AADED07952BQ24200364-C8AC71F0-B196-4CF0-8E3A-D414FF718482Q24235301-57394580-6390-4465-AA78-C865C61B9DA6Q24243152-01620B5F-8B75-4AB0-AC10-E171BE7C3072Q24244072-0FCAA54B-9989-4E03-B52C-00C63C7887A2Q24246180-72709E43-1EC9-4DCA-ACB9-F11010B33BF1Q24650594-3CBAE777-422E-4F62-9AC7-5FE5E4729A33Q30376510-D83E431B-5A38-4146-9013-E8B5D4EB9333Q30470229-47B9D407-0526-4B4D-9F55-F5FE055DEC47Q30483150-B3E2955D-2B2D-4744-A616-A225D38ED184Q30835191-80BF68CB-ACFD-43A2-A06C-320BC5168AE0Q31138746-83F256AF-646C-40FA-933D-B79FA2466028Q33882729-01C1AD60-7618-4750-8A7C-6AC9773C12E2Q33893244-DEC5BC64-2355-408B-AF70-32E794DB019BQ33925174-93AC41BB-C024-4C4C-91F9-CCE90EFD0977Q34095888-90D1F560-B161-4D20-8D12-D62E2BA52405Q34187170-9124F33F-61DB-4E19-B12E-45E3C77378A2Q34347356-A2A58328-E5AF-4697-87F1-4521F6B07E7DQ34386214-0174983F-7969-4744-9823-F0E6A2829537Q34499617-B4015782-86B4-45F6-9CC9-D2695B029CDCQ34707472-50075318-1484-4EFF-9AEA-D32F0970BAF5Q34721927-1716D092-0A57-4660-A4AC-EC4C9FF03085Q34729021-EA5A64F6-0B5B-43D4-B330-9B777A4089DBQ34923237-7125F9FF-6192-4ACE-AA15-C61483E4C6ACQ35163187-5D829497-ACB3-477D-9836-5D6FCBE2534EQ35176773-5676E806-DFB2-4804-8360-1F83CFA16133Q35327869-4B279EB1-F066-41E2-8E6C-6767545A9AE2Q35666551-7CEB2412-B812-48BD-91B4-62124A2448FCQ35825226-E18239CB-41AF-40BD-B2BE-B4B240E7C0BAQ35848953-4439B5A9-FC04-4387-A2CB-9F627EDDA9A1Q35861739-45F1DDAA-08DA-4243-9076-70F5EAC684B1Q35873850-A488A374-9E41-482E-86AB-2BE0CE57092FQ35900341-39A09680-9C31-4384-A60E-C2CD975D861BQ35947322-E0B65B6C-94AE-4365-91E7-FDFB037F8C1FQ35954635-BFC30F2E-EDE1-4D22-895E-082A35DD0838Q36096550-4109DCC5-1BDE-45F3-9455-41C8F57E4F6FQ36098797-DF0717B9-A23A-4B42-85E8-28E715625AA6
P2860
A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A randomized controlled trial ...... hrenia resistant to medication
@ast
A randomized controlled trial ...... hrenia resistant to medication
@en
A randomized controlled trial ...... hrenia resistant to medication
@nl
type
label
A randomized controlled trial ...... hrenia resistant to medication
@ast
A randomized controlled trial ...... hrenia resistant to medication
@en
A randomized controlled trial ...... hrenia resistant to medication
@nl
prefLabel
A randomized controlled trial ...... hrenia resistant to medication
@ast
A randomized controlled trial ...... hrenia resistant to medication
@en
A randomized controlled trial ...... hrenia resistant to medication
@nl
P2093
P3181
P1433
P1476
A randomized controlled trial ...... hrenia resistant to medication
@en
P2093
D Turkington
M O'Carroll
T R Barnes
P304
P3181
P356
10.1001/ARCHPSYC.57.2.165
P407
P50
P577
2000-02-01T00:00:00Z